Phoebe Mounts's most recent trade in CorMedix Inc was a trade of 125,000 Stock Option (Right to Buy Common Stock) done . Disclosure was reported to the exchange on Jan. 14, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
CorMedix Inc | Phoebe Mounts | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2023 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy Common Stock) | |
CorMedix Inc | Phoebe Mounts | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy) | |
CorMedix Inc | Phoebe Mounts | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy Common Stock) | |
CorMedix Inc | Phoebe Mounts | General Counsel | Purchase of securities on an exchange or from another person at price $ 4.03 per share. | 13 Aug 2020 | 2,525 | 7,200 (0%) | 0% | 4.0 | 10,176 | Common Stock |